Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.

Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol EKSO
- Company Ekso Bionics Holdings, Inc.
- Price $0.46
- Changes Percentage 13.67
- Change 0.0553
- Day Low $0.4
- Day High $0.48
- Year High $1.53
- Year Low $0.34
- Market Cap $11,416,926
- Price Avg 50 EMA (D) $0.58
- Price Avg 200 EMA (D) $0.9
- Exchange NASDAQ
- Volume 381,816
- Average Volume 1,195,477
- Open $0.4
- Previous Close $0.4
- EPS -0.56
- PE -0.82
- Earnings Announcement 2025-04-28 10:59:00
- Shares Outstanding $24,824,800
Company brief: EKSO BIONICS HOLDINGS, INC. (EKSO )
- Healthcare
- Medical - Instruments & Supplies
- Mr. Scott G. Davis
- https://www.eksobionics.com
- US
- N/A
- 01-17-2014
- US2826443010
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.